TABLE 2.
Baseline | Six-month follow-up | |||||||
---|---|---|---|---|---|---|---|---|
Intervention | Control | Intervention | Control | |||||
n | Mean ± SD | n | Mean ± SD | n | Mean ± SD | n | Mean ± SD | |
Plasma choline, µmol/L | 30 | 17.0 ± 3.3 | 30 | 17.2 ± 3.8 | 30 | 15.5 ± 4.3 | 30 | 13.7 ± 2.6 |
Plasma betaine, µmol/L | 30 | 86.3 ± 34.8 | 30 | 83.8 ± 28.4 | 30 | 101.6 ± 34.3 | 30 | 91.7 ± 35.1 |
Plasma TMAO,2 µmol/L | 30 | 1.0 (0.6, 2.9) | 30 | 2.3 (1.3, 4.7) | 30 | 3.8 (2.5, 6.7) | 30 | 3.3 (1.8, 4.5) |
TMAO, trimethylamine N-oxide.
Variable was skewed; data presented are median (IQR).